ProPhase Labs, Inc.
PRPH
$0.11
-$0.02-16.57%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 908.80% | -11.64% | -67.59% | -80.65% | -101.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 908.80% | -11.64% | -67.59% | -80.65% | -101.00% |
| Cost of Revenue | 30.64% | -46.38% | -58.59% | -64.38% | -90.31% |
| Gross Profit | 126.40% | 181.44% | -91.24% | -100.96% | -112.23% |
| SG&A Expenses | 9.59% | 9.95% | 6.89% | 13.29% | -29.21% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.45% | -4.41% | -15.19% | -19.22% | -59.42% |
| Operating Income | 8.32% | 3.00% | -16.60% | -82.04% | -110.40% |
| Income Before Tax | 0.56% | -2.87% | -25.33% | -88.99% | -111.81% |
| Income Tax Expenses | 247.72% | 236.30% | 213.53% | 219.56% | -75.67% |
| Earnings from Continuing Operations | -103.95% | -94.83% | -116.79% | -202.35% | -131.99% |
| Earnings from Discontinued Operations | 357.39% | 535.78% | 848.45% | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -50.25% | -57.55% | -82.79% | -217.98% | -164.97% |
| EBIT | 8.32% | 3.00% | -16.60% | -82.04% | -110.40% |
| EBITDA | 6.92% | 1.14% | -22.40% | -113.86% | -160.45% |
| EPS Basic | -15.19% | -31.04% | -58.96% | -168.47% | -144.53% |
| Normalized Basic EPS | 38.78% | 27.41% | 3.02% | -58.24% | -99.34% |
| EPS Diluted | -15.29% | -31.07% | -58.93% | -168.35% | -144.32% |
| Normalized Diluted EPS | 38.78% | 27.41% | 3.02% | -57.95% | -98.84% |
| Average Basic Shares Outstanding | 89.54% | 63.10% | 35.21% | 12.50% | 9.26% |
| Average Diluted Shares Outstanding | 89.54% | 63.10% | 35.21% | 10.37% | 7.16% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |